196 related articles for article (PubMed ID: 9085208)
1. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease.
Voto LS; Mathet ER; Zapaterio JL; Orti J; Lede RL; Margulies M
J Perinat Med; 1997; 25(1):85-8. PubMed ID: 9085208
[TBL] [Abstract][Full Text] [Related]
2. Fetal hematocrit decrease after repeated intravascular transfusions in alloimmunized pregnancies.
Lobato G; Soncini CS
Arch Gynecol Obstet; 2007 Dec; 276(6):595-9. PubMed ID: 17572904
[TBL] [Abstract][Full Text] [Related]
3. Predicting Intrauterine Transfusion Interval and Perinatal Outcomes in Alloimmunized Pregnancies: Time-to-Event Survival Analysis.
Snelgrove JW; D'Souza R; Seaward PGR; Windrim R; Kelly EN; Ryan G
Fetal Diagn Ther; 2019; 46(6):425-432. PubMed ID: 31195389
[TBL] [Abstract][Full Text] [Related]
4. Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation.
Lindenburg IT; van Kamp IL; van Zwet EW; Middeldorp JM; Klumper FJ; Oepkes D
BJOG; 2013 Jun; 120(7):847-52. PubMed ID: 23551577
[TBL] [Abstract][Full Text] [Related]
5. Experience with intrauterine transfusions for severe Rh alloimmunization in a developing country.
Gupte SC; Lulla CP; Kulkarni SS; Korgaonkar SA; Walvekar VR; Merchant RH
J Matern Fetal Med; 1998; 7(6):287-91. PubMed ID: 9848694
[TBL] [Abstract][Full Text] [Related]
6. [Intrauterine transfusión in alloimmunization Rh in México 1987-2008].
Ramírez-Robles LJ; Gómez-Partida G; Guevara-Rubio G; Velázquez-Gómez L
Ginecol Obstet Mex; 2010 Sep; 78(9):469-77. PubMed ID: 21961364
[TBL] [Abstract][Full Text] [Related]
7. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
[TBL] [Abstract][Full Text] [Related]
8. Benefits and risks of fetal red-cell transfusion after 32 weeks gestation.
Klumper FJ; van Kamp IL; Vandenbussche FP; Meerman RH; Oepkes D; Scherjon SA; Eilers PH; Kanhai HH
Eur J Obstet Gynecol Reprod Biol; 2000 Sep; 92(1):91-6. PubMed ID: 10986440
[TBL] [Abstract][Full Text] [Related]
9. No beneficial effect of low-dose fetal intravenous gammaglobulin administration in combination with intravascular transfusions in severe Rh D haemolytic disease.
Dooren MC; van Kamp IL; Scherpenisse JW; Brand R; Ouwehand WH; Kanhai HH; Engelfriet CP; Gravenhorst JB
Vox Sang; 1994; 66(4):253-7. PubMed ID: 8079448
[TBL] [Abstract][Full Text] [Related]
10. Fetal middle cerebral artery Doppler to time intrauterine transfusion in red-cell alloimmunization: a randomized trial.
Dodd JM; Andersen C; Dickinson JE; Louise J; Deussen A; Grivell RM; Voto L; Kilby MD; Windrim R; Ryan G;
Ultrasound Obstet Gynecol; 2018 Mar; 51(3):306-312. PubMed ID: 28700818
[TBL] [Abstract][Full Text] [Related]
11. Outcome predictors for maternal red blood cell alloimmunisation with anti-K and anti-D managed with intrauterine blood transfusion.
Vlachodimitropoulou E; Garbowski M; Anne Solomon S; Abbasi N; Seaward G; Windrim R; Keunen J; Kelly E; Van Mieghem T; Shehata N; Ryan G
Br J Haematol; 2022 Feb; 196(4):1096-1104. PubMed ID: 34862601
[TBL] [Abstract][Full Text] [Related]
12. Direct fetal intravenous immunoglobulin infusion as an adjunct to intrauterine fetal blood transfusion in rhesus-allommunized pregnancies: a pilot study.
Deka D; Sharma KA; Dadhwal V; Singh A; Kumar G; Vanamail P
Fetal Diagn Ther; 2013; 34(3):146-51. PubMed ID: 23941890
[TBL] [Abstract][Full Text] [Related]
13. Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: A case-control study.
Maisonneuve E; Dugas A; Friszer S; Toly-Ndour C; Cariot L; Dhombres F; Cortey A; Mailloux A; Carbonne B; Jouannic JM
J Gynecol Obstet Hum Reprod; 2021 Sep; 50(7):102119. PubMed ID: 33741541
[TBL] [Abstract][Full Text] [Related]
14. Successful management of fetal hemolytic disease due to strong anti-Rh17 with plasma exchange and intrauterine transfusion in a woman with the D-- phenotype.
Mimura K; Endo M; Takahashi A; Doi Y; Sakuragi M; Kiyokawa T; Taniguchi H; Kitabatake Y; Handa M; Tomimatsu T; Tomiyama Y; Isaka Y; Kimura T
Int J Hematol; 2020 Jan; 111(1):149-154. PubMed ID: 31538326
[TBL] [Abstract][Full Text] [Related]
15. Neonatal outcome of fetuses receiving intrauterine transfusion for severe hydrops complicated by Rhesus hemolytic disease.
Altunyurt S; Okyay E; Saatli B; Canbahishov T; Demir N; Ozkan H
Int J Gynaecol Obstet; 2012 May; 117(2):153-6. PubMed ID: 22342051
[TBL] [Abstract][Full Text] [Related]
16. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
Zwiers C; van der Bom JG; van Kamp IL; van Geloven N; Lopriore E; Smoleniec J; Devlieger R; Sim PE; Ledingham MA; Tiblad E; Moise KJ; Gloning KP; Kilby MD; Overton TG; Jørgensen DS; Schou KV; Paek B; Walker M; Parry E; Oepkes D; de Haas M
Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
[TBL] [Abstract][Full Text] [Related]
17. Relationship between obstetric history and Rh(D) alloimmunization severity.
Lobato G; Soncini CS
Arch Gynecol Obstet; 2008 Mar; 277(3):245-8. PubMed ID: 17763861
[TBL] [Abstract][Full Text] [Related]
18. Ultrasound-facilitated intrauterine transfusions.
Acker D; Frigoletto FD; Birnholz JC; Umansky I; Phillippe M; Finberg HJ; Lieberman M
Am J Obstet Gynecol; 1980 Dec; 138(8):1200-4. PubMed ID: 7446629
[TBL] [Abstract][Full Text] [Related]
19. Intrauterine transfusion in 103 fetuses with severe anemia caused by parvovirus infection. A multicenter retrospective study.
Kosian P; Hellmund A; Geipel A; Bald R; Geist OM; Böckenhoff P; Jimenez-Cruz J; Deja M; Strizek B; Berg C; Gembruch U
Arch Gynecol Obstet; 2023 Jul; 308(1):117-125. PubMed ID: 35916962
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic plasma exchange and intravenous immunoglobulin as primary therapy for D alloimmunization in pregnancy precludes the need for intrauterine transfusion.
Bellone M; Boctor FN
Transfusion; 2014 Aug; 54(8):2118-21. PubMed ID: 24673470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
